In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Announcement
GSK Students Win Grants to Fund Innovative Cancer Research

Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer research.
Colored scanning electron micrograph of a clump of pluripotent stem cells.
In the Lab
Stem Cells Stay “Young” on a Fat-Free Diet

Researchers have discovered a simple way to keep stem cells in a more flexible state for research and potential treatments.
Surviving with Pride: Obstacles and Opportunities for LGBTQ+ Cancer Survivors

Today is the fourth anniversary of same-sex marriage being legalized in the United States. Today also marks the start of WorldPride, which celebrates the progress made toward LGBTQ+ equality while underscoring changes still needed.
MSK cancer researchers Elizabeth Adams, Charles Sawyers, and Rohit Bose
In the Lab
Researchers Unravel the Biology of a Distinct Prostate Cancer Subtype

Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found.
holding hands
Feature
Hard Conversations: How to Talk to Your Care Team and Loved Ones about Dying

Follow these guidelines for holding difficult yet important end-of-life conversations.
An illustration of a samurai and a crab.
In the Lab
Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal

Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
Doctor with back to camera speaking with smiling girl.
In the Clinic
Proton Therapy: A Safer Way to Eliminate Tumors in Kids

Proton therapy offers a way to treat pediatric cancers more safely.
Immune cells surrounding a cancer cell
In the Lab
Checkpoint Challenge: When Releasing Immune Cell Brakes Is Not Enough to Stop Cancer

Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
MSK patient Kara Kenny hugging medical oncologist Diane Reidy Lagunes
Feature
Coping with Rectal Cancer: A Young Mother’s Story of Determination and Compassion

Learn how MSK is helping a young mother cope with rectal cancer through the Center for Young Onset Colorectal Cancer, the first program in the country devoted to younger adults with this disease.
MSK-ACCESS Receives New York State Approval for New Molecular Assay

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.